181 related articles for article (PubMed ID: 28182126)
1. The role of surface charge in the desolvation process of gelatin: implications in nanoparticle synthesis and modulation of drug release.
Ahsan SM; Rao CM
Int J Nanomedicine; 2017; 12():795-808. PubMed ID: 28182126
[TBL] [Abstract][Full Text] [Related]
2. Matrix-loaded biodegradable gelatin nanoparticles as new approach to improve drug loading and delivery.
Ofokansi K; Winter G; Fricker G; Coester C
Eur J Pharm Biopharm; 2010 Sep; 76(1):1-9. PubMed ID: 20420904
[TBL] [Abstract][Full Text] [Related]
3. In situ DOX-calcium phosphate mineralized CPT-amphiphilic gelatin nanoparticle for intracellular controlled sequential release of multiple drugs.
Li WM; Su CW; Chen YW; Chen SY
Acta Biomater; 2015 Mar; 15():191-9. PubMed ID: 25542535
[TBL] [Abstract][Full Text] [Related]
4. Structural studies on aqueous gelatin solutions: Implications in designing a thermo-responsive nanoparticulate formulation.
Ahsan SM; Rao CM
Int J Biol Macromol; 2017 Feb; 95():1126-1134. PubMed ID: 27815123
[TBL] [Abstract][Full Text] [Related]
5. Gelatin nanoparticles by two step desolvation--a new preparation method, surface modifications and cell uptake.
Coester CJ; Langer K; van Briesen H; Kreuter J
J Microencapsul; 2000; 17(2):187-93. PubMed ID: 10738694
[TBL] [Abstract][Full Text] [Related]
6. Optimization of a two-step desolvation method for preparing gelatin nanoparticles and cell uptake studies in 143B osteosarcoma cancer cells.
Azarmi S; Huang Y; Chen H; McQuarrie S; Abrams D; Roa W; Finlay WH; Miller GG; Löbenberg R
J Pharm Pharm Sci; 2006; 9(1):124-32. PubMed ID: 16849014
[TBL] [Abstract][Full Text] [Related]
7. Genipin-modified gelatin nanocarriers as swelling controlled drug delivery system for in vitro release of cytarabine.
Khan H; Shukla RN; Bajpai AK
Mater Sci Eng C Mater Biol Appl; 2016 Apr; 61():457-65. PubMed ID: 26838872
[TBL] [Abstract][Full Text] [Related]
8. Gelatin nanocarriers as potential vectors for effective management of tuberculosis.
Saraogi GK; Gupta P; Gupta UD; Jain NK; Agrawal GP
Int J Pharm; 2010 Jan; 385(1-2):143-9. PubMed ID: 19819315
[TBL] [Abstract][Full Text] [Related]
9. New method and characterization of self-assembled gelatin-oleic nanoparticles using a desolvation method via carbodiimide/N-hydroxysuccinimide (EDC/NHS) reaction.
Park C; Vo CL; Kang T; Oh E; Lee BJ
Eur J Pharm Biopharm; 2015 Jan; 89():365-73. PubMed ID: 25536111
[TBL] [Abstract][Full Text] [Related]
10. Exploring gelatin nanoparticles as novel nanocarriers for Timolol Maleate: Augmented in-vivo efficacy and safe histological profile.
Shokry M; Hathout RM; Mansour S
Int J Pharm; 2018 Jul; 545(1-2):229-239. PubMed ID: 29709617
[TBL] [Abstract][Full Text] [Related]
11. Optimisation of one-step desolvation and scale-up of gelatine nanoparticle production.
Geh KJ; Hubert M; Winter G
J Microencapsul; 2016 Nov; 33(7):595-604. PubMed ID: 27556342
[TBL] [Abstract][Full Text] [Related]
12. Exploiting gelatin nanocarriers in the pulmonary delivery of methotrexate for lung cancer therapy.
Abdelrady H; Hathout RM; Osman R; Saleem I; Mortada ND
Eur J Pharm Sci; 2019 May; 133():115-126. PubMed ID: 30905615
[TBL] [Abstract][Full Text] [Related]
13. Encapsulation of Fe3O4 in gelatin nanoparticles: effect of different parameters on size and stability of the colloidal dispersion.
Gaihre B; Aryal S; Khil MS; Kim HY
J Microencapsul; 2008 Feb; 25(1):21-30. PubMed ID: 18188729
[TBL] [Abstract][Full Text] [Related]
14. Improved Stability and Enhanced Oral Bioavailability of Atorvastatin Loaded Stearic Acid Modified Gelatin Nanoparticles.
Shilpi D; Kushwah V; Agrawal AK; Jain S
Pharm Res; 2017 Jul; 34(7):1505-1516. PubMed ID: 28466393
[TBL] [Abstract][Full Text] [Related]
15. Desolvation process and surface characterisation of protein nanoparticles.
Weber C; Coester C; Kreuter J; Langer K
Int J Pharm; 2000 Jan; 194(1):91-102. PubMed ID: 10601688
[TBL] [Abstract][Full Text] [Related]
16. Gelatin-coated magnetic iron oxide nanoparticles as carrier system: drug loading and in vitro drug release study.
Gaihre B; Khil MS; Lee DR; Kim HY
Int J Pharm; 2009 Jan; 365(1-2):180-9. PubMed ID: 18790029
[TBL] [Abstract][Full Text] [Related]
17. Recombinant human gelatin nanoparticles as a protein drug carrier.
Won YW; Kim YH
J Control Release; 2008 Apr; 127(2):154-61. PubMed ID: 18329122
[TBL] [Abstract][Full Text] [Related]
18. Moxifloxacin loaded gelatin nanoparticles for ocular delivery: Formulation and in-vitro, in-vivo evaluation.
Mahor A; Prajapati SK; Verma A; Gupta R; Iyer AK; Kesharwani P
J Colloid Interface Sci; 2016 Dec; 483():132-138. PubMed ID: 27552421
[TBL] [Abstract][Full Text] [Related]
19. Regulated Drug Release Abilities of Calcium Carbonate-Gelatin Hybrid Nanocarriers Fabricated via a Self-Organizational Process.
Murai K; Kurumisawa K; Nomura Y; Matsumoto M
ChemMedChem; 2017 Oct; 12(19):1595-1599. PubMed ID: 28741844
[TBL] [Abstract][Full Text] [Related]
20. Preparation of magnetic gelatin nanoparticles and investigating the possible use as chemotherapeutic agent.
Yılmaz H; Sanlıer SH
Artif Cells Nanomed Biotechnol; 2013 Apr; 41(2):69-77. PubMed ID: 23305120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
